Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
A Randomized Study for Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Patients Preparing for Kidney Transplantation
1 other identifier
interventional
800
1 country
1
Brief Summary
Study the prevalence of LTBI in patients who are waiting renal transplant and monitor the incidence of active TB
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 11, 2016
CompletedFirst Posted
Study publicly available on registry
May 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 15, 2016
December 1, 2016
3.9 years
May 11, 2016
December 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of active TB
4 years
Study Arms (4)
Waiting for renal transplant_no screening of LTBI
NO INTERVENTIONpatients with renal failure and are waiting for renal transplant We do routine examination but no LTBI check
Not waiting for renal transplant
PLACEBO COMPARATORDialysis patients who are not waiting for renal transplant
Status post renal transplant
OTHERpatients who have received renal transplant
Waiting for renal transplant_ screening of LTBI
EXPERIMENTALpatients with renal failure and are waiting for renal transplant We do routine examination in addition to LTBI check
Interventions
Eligibility Criteria
You may qualify if:
- Age between 20-65 and match one of below
- Waiting renal transplant or status post renal transplant
- Receiving long term dialysis
You may not qualify if:
- Not agree to be enrolled
- Suspected active TB
- HIV patients
- Viral hepatitis
- Using immunosuppressants within 3 months before enrollment
- Receiving lymphokine therapy
- Hemoglobin \< 8 g/dL
- Serum bilirubin \> 2.5 mg/dL
- AST or ALT \> 2 times of upper normal limit
- Lactation or pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chin-Chung Shu, MD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2016
First Posted
May 25, 2016
Study Start
January 1, 2014
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
December 15, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share